Bausch + Lomb Corporation specializes in eye health products, including contact lenses and surgical instruments, with a strong presence in North America and Europe. The company leverages its extensive product portfolio and brand recognition to maintain a competitive edge in the ophthalmic market.
Business Overview
Bausch + Lomb generates revenue primarily through the sale of contact lenses, surgical instruments, and pharmaceuticals for eye care. The company benefits from strong brand loyalty and pricing power in its contact lens segment, particularly with premium products like its daily disposable lenses.
Changes in consumer demand for contact lenses and eye care products
Regulatory approvals for new surgical devices
Market share shifts in the ophthalmic pharmaceutical sector
Pricing pressures from competitors
Risk Factors
Technological disruption in eye care treatments and devices
Regulatory changes impacting product approvals and market access
Intense competition from other established players like Johnson & Johnson and Alcon
Emerging startups offering innovative eye care solutions
Negative net income impacting investor perception and stock valuation
Potential liquidity risks due to negative free cash flow
Macro Sensitivity
moderate - The demand for eye care products is somewhat resilient during economic downturns, but luxury segments like premium contact lenses may see reduced spending.
Interest rates affect Bausch + Lomb primarily through the cost of financing for R&D and capital expenditures, as well as consumer spending on non-essential healthcare products.
minimal - The company's low debt levels (Debt/Equity of 0.01) reduce its exposure to credit conditions.
Profile
value - Investors may be drawn to the stock due to its low price-to-book ratio (0.8x) and potential for recovery in margins.
moderate - The stock has shown historical volatility, with a 1-year return of 22.3% but recent declines indicating potential instability.
Explore More
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
